Team

At Oak Hill Bio, we are dedicated to advancing highly promising therapies with the potential to transform the lives of patients suffering from rare diseases.

Headshot from a team member.
Josh Distler, J.D.
Chief Executive Officer
Headshot from a team member.
Ike Greenstein, M.B.A.
Chief Financial Officer
Headshot from a team member.
Sharon Morriss, Ph.D.
Chief Operating Officer
Headshot from a team member.
Brenda Vincenzi, M.D.
Chief Medical Officer
Headshot of a team member.
Brenda Vincenzi, M.D.
Chief Medical Officer
Headshot from a team member.
Josh Distler, J.D.
Chief Executive Officer
Headshot from a team member.
Ike Greenstein, M.B.A.
Chief Financial Officer
Headshot from a team member.
Sharon Morriss, Ph.D.
Chief Operating Officer
Headshot from a team member.
Brenda Vincenzi, M.D.
Chief Medical Officer

Board of Directors

Headshot of a team member.
Josh Distler, J.D.
Headshot of a team member.
Doug Fambrough, Ph.D.
Headshot of a team member.
Rich Gaster M.D., Ph.D.
Headshot of a team member.
Sandeep Kulkarni, M.D.
Headshot of a team member.
Parvinder Thiara

Investors

Oak Hill Bio is backed by a strong syndicate of experienced life science investors.